Finch Therapeutics Group, Inc. (FNCH) Financials

FNCH Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 59.5 million 33.7 million
2023-06-30 66.9 million 39.0 million
2023-03-31 79.0 million 46.1 million
2022-12-31 162.9 million 67.2 million

FNCH Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -5.3 million 335000
2023-06-30 -9.2 million 300000
2023-03-31 -13.4 million 1.2 million
2022-12-31 -14.3 million 1.8 million

FNCH Net Income

No data available :(

FNCH Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 28.8 million - 30.8 million
2023-06-30 34.1 million - 31.0 million
2023-03-31 41.7 million - 36.1 million
2022-12-31 71.0 million - 37.7 million

FNCH Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 1.6 million
2023-06-30 1.6 million
2023-03-31 1.6 million
2022-12-31 1.6 million

FNCH Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - - 3.7 million -
2023-06-30 - 203000 8.9 million -
2023-03-31 14000 8.6 million 9.6 million -
2022-12-31 51000 16.6 million 10.9 million -

FNCH Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 52000
2023-06-30 - 57000
2023-03-31 107000 1.4 million
2022-12-31 8000 1.4 million

FNCH

Price: $2.33

52 week price:
1.86
16.74

Earnings Per Share: -46.59 USD

P/E Ratio: -0.04

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 136300

Market Capitalization: 3.3 million

Links: